Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18692643rdf:typepubmed:Citationlld:pubmed
pubmed-article:18692643lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18692643lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:18692643lifeskim:mentionsumls-concept:C0162857lld:lifeskim
pubmed-article:18692643lifeskim:mentionsumls-concept:C0003018lld:lifeskim
pubmed-article:18692643lifeskim:mentionsumls-concept:C0042396lld:lifeskim
pubmed-article:18692643lifeskim:mentionsumls-concept:C0006669lld:lifeskim
pubmed-article:18692643lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:18692643pubmed:issue2lld:pubmed
pubmed-article:18692643pubmed:dateCreated2008-8-11lld:pubmed
pubmed-article:18692643pubmed:abstractTextThe radial artery is increasingly used for coronary artery bypass grafts, but its potential for spasm increases postoperative risk. Alpha-calcitonin gene-related peptide is a potent antihypertensive peptide. Thus, we set out to determine whether calcitonin gene-related peptide can impair angiotensin II-mediated vasoconstriction in human radial arteries and, if so, to determine its mechanism of action.lld:pubmed
pubmed-article:18692643pubmed:languageenglld:pubmed
pubmed-article:18692643pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18692643pubmed:statusMEDLINElld:pubmed
pubmed-article:18692643pubmed:monthAuglld:pubmed
pubmed-article:18692643pubmed:issn1097-685Xlld:pubmed
pubmed-article:18692643pubmed:authorpubmed-author:BuxtonBrian...lld:pubmed
pubmed-article:18692643pubmed:authorpubmed-author:WookeyPeter...lld:pubmed
pubmed-article:18692643pubmed:authorpubmed-author:HareDavid LDLlld:pubmed
pubmed-article:18692643pubmed:authorpubmed-author:ZulliAnthonyAlld:pubmed
pubmed-article:18692643pubmed:authorpubmed-author:YeBeiBlld:pubmed
pubmed-article:18692643pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18692643pubmed:volume136lld:pubmed
pubmed-article:18692643pubmed:ownerNLMlld:pubmed
pubmed-article:18692643pubmed:authorsCompleteYlld:pubmed
pubmed-article:18692643pubmed:pagination370-5lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:meshHeadingpubmed-meshheading:18692643...lld:pubmed
pubmed-article:18692643pubmed:year2008lld:pubmed
pubmed-article:18692643pubmed:articleTitleCalcitonin gene-related peptide inhibits angiotensin II-mediated vasoconstriction in human radial arteries: role of the Kir channel.lld:pubmed
pubmed-article:18692643pubmed:affiliationDepartment of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia. azulli@unimelb.edu.aulld:pubmed
pubmed-article:18692643pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18692643pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:18692643pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed